Welcome to AMYPAD!

We are a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) initiative aims to:

Homepage Image Neuraceq™ (left) and Vizamyl™ (right). Upper images: amyloid negative scans. Lower images: amyloid positive scans.
Latest News
Michael Schöll awarded by The Royal Society of Arts and Sciences
Michael Schöll awarded by The Royal Society of Arts and Sciences 14 Jan 2021 Congratulations to Michael Schöll for receiving the "Birger Karlsson Science Award"......
Welcome to the 15th issue of the AMYPAD newsletter
Welcome to the 15th issue of the AMYPAD newsletter 11 Dec 2020 I am thrilled that - COVID notwithstanding - we have managed to successfully complete the enrolment of the AMYPAD DPMS, thanks to the great efforts of all of you......
Lyduine Collij and Gemma Salvado win Junior Faculty Awards
Lyduine Collij and Gemma Salvado win Junior Faculty Awards 09 Dec 2020 Lyduine Collij and Gemma Salvadó have been awarded the Junior Faculty Awards from the organizing committee of the AD/PD™ 2021......
Recruitment status (as 1 December, 2020)
Recruitment status (as 1 December, 2020)

AMYPAD recruitment update